Drug
Cagrilintide clinical trials
Also written NNC0174-0833.
- studies test it
- 47
- open now
- 10
- in phase 3
- 22
- first study started
- 2014
Keep track of what changes. Save the cagrilintide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
47 studies that test it; most in 2026 (12)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 8 |
| 2024 | 11 |
| 2025 | 6 |
| 2026 | 12 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 19
- Phase 2
- 6
- Phase 3
- 22
What it is tested for
Each study’s main condition, where its own words name it.
- Obesity
- 28
Who runs them
Industry 47 · Other 0
Often tested with
Tested in the same studies.
Semaglutide (22) · Tirzepatide (1) · Zalfermin (1) · Contraceptives, Oral (1)
Studies
Open first, then newest update. How each study uses cagrilintide is read from its arms, and is right about nine times in ten.
Testing it · 47
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 DiabetesRecruitingPhase 3Novo Nordisk A/SNCT07282613Written as CagriSema (Cagrilintide B and Semaglutide I)
- Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse EventsRecruitingPhase 1Novo Nordisk A/SNCT07607587Written as Cagrilintide
- A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body WeightRecruitingPhase 3Novo Nordisk A/SNCT07253285Written as Cagrilintide
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightRecruitingPhase 3Novo Nordisk A/SNCT07564414Written as Cagrisema
- Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to CagrisemaRecruitingPhase 3Novo Nordisk A/SNCT07817251Written as CagriSema
- The Role of the Amylin Analogue Cagrilintide in Bone MetabolismRecruitingPhase 1Novo Nordisk A/SNCT07010432Written as Cagrilintide
- A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body WeightRecruitingPhase 3Novo Nordisk A/SNCT07745504Written as Cagrilintide
- A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or ObesityRecruitingPhase 1Novo Nordisk A/SNCT07597018Written as Cagrilintide D
- A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or ObesityRecruitingPhase 1Novo Nordisk A/SNCT07557953Written as Cagrilintide
- Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)RecruitingPhase 1Novo Nordisk A/SNCT07527195Written as Cagrilintide
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorCompletedPhase 3Novo Nordisk A/SNCT06221969Written as Cagrilintide
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or BothCompletedPhase 3Novo Nordisk A/SNCT06534411Written as Cagrilintide
- Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With CagrilintideActive, not recruitingPhase 3Novo Nordisk A/SNCT07220759Written as Cagrilintide
- A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose WeightActive, not recruitingPhase 3Novo Nordisk A/SNCT05567796Written as Cagrilintide
- A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-termActive, not recruitingPhase 3Novo Nordisk A/SNCT07011667Written as CagriSema (Cagrilintide B and Semaglutide I)
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and ExerciseCompletedPhase 3Novo Nordisk A/SNCT06323174Written as Cagrilintide
- A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and PlaceboCompletedPhase 2Novo Nordisk A/SNCT06131372Written as Cagrilintide
- A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral NeuropathyCompletedPhase 2Novo Nordisk A/SNCT06797869Written as CagriSema (Cagrilintide B and Semaglutide I)
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without MetforminCompletedPhase 3Novo Nordisk A/SNCT06323161Written as Cagrilintide
- A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body WeightCompletedPhase 1Novo Nordisk A/SNCT07605052Written as Cagrilintide B
See all 47 studies that test cagrilintide →
Given in every arm · 4 — cagrilintide is usual care beside what is tested
- A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or ObeseRecruitingPhase 1Novo Nordisk A/SNCT07411560Written as Cagrilintide
- A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to DietActive, not recruitingPhase 1Novo Nordisk A/SNCT07184086Written as CagriSema (Cagrilintide B + semaglutide I)
- A Study on How NNC0174-1213 Works in People With Overweight or Obesity.CompletedPhase 1Novo Nordisk A/SNCT06719011Written as Cagrilintide B
- A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body WeightCompletedPhase 1Novo Nordisk A/SNCT06289504Written as Cagrilintide
Codes
What other systems call cagrilintide · ClinicalTrials.gg INT001638
- MeSH (NLM) C000717792cagrilintideConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) AO43BIF1U8CAGRILINTIDEConfirmed FDA, NLM
- NCI Thesaurus C175752CagrilintideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000717792 | cagrilintide | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | AO43BIF1U8 | CAGRILINTIDE | Confirmed FDA, NLM |
| NCI Thesaurus | C175752 | Cagrilintide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.